SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARZOLA, Erika
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.940
AS - Asia 2.586
EU - Europa 1.671
SA - Sud America 389
AF - Africa 71
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.668
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.836
SG - Singapore 1.030
CN - Cina 596
IT - Italia 435
VN - Vietnam 305
BR - Brasile 272
DE - Germania 259
HK - Hong Kong 207
GB - Regno Unito 173
PL - Polonia 165
UA - Ucraina 161
FI - Finlandia 113
TR - Turchia 112
FR - Francia 102
JP - Giappone 67
SE - Svezia 62
CA - Canada 57
IN - India 57
RU - Federazione Russa 56
ID - Indonesia 47
AR - Argentina 40
MX - Messico 35
NL - Olanda 31
ZA - Sudafrica 31
BD - Bangladesh 29
BE - Belgio 27
CO - Colombia 26
PK - Pakistan 21
IQ - Iraq 20
LT - Lituania 17
EC - Ecuador 14
ES - Italia 14
IR - Iran 12
SA - Arabia Saudita 12
AT - Austria 11
IE - Irlanda 11
PH - Filippine 11
UY - Uruguay 9
MY - Malesia 8
TN - Tunisia 8
UZ - Uzbekistan 8
CL - Cile 7
DZ - Algeria 7
PY - Paraguay 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CZ - Repubblica Ceca 6
IL - Israele 6
JO - Giordania 6
MA - Marocco 6
AL - Albania 5
BG - Bulgaria 5
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
RO - Romania 4
BO - Bolivia 3
HU - Ungheria 3
KR - Corea 3
LB - Libano 3
NI - Nicaragua 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
CH - Svizzera 2
ET - Etiopia 2
NA - Namibia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
QA - Qatar 1
Totale 9.663
Salva come PNG Salva come JPEG
Città #
Singapore 672
Ashburn 666
Fairfield 423
Woodbridge 404
San Jose 347
Ann Arbor 238
Beijing 223
Houston 222
Santa Clara 207
Hong Kong 199
Seattle 186
Jacksonville 169
Chandler 166
Ferrara 165
Warsaw 159
Cambridge 149
Wilmington 147
New York 114
Ho Chi Minh City 101
Munich 89
Los Angeles 84
Dallas 77
Milan 67
Tokyo 66
Hanoi 61
Izmir 60
Princeton 52
Lauterbourg 50
Helsinki 48
Dearborn 47
Nanjing 47
Addison 44
Council Bluffs 43
Shanghai 40
San Diego 37
Jakarta 33
Boardman 31
Turku 31
São Paulo 30
London 27
The Dalles 26
Brussels 25
Frankfurt am Main 25
Bologna 23
Orem 22
Atlanta 21
Mexico City 21
Johannesburg 20
Montreal 20
Falkenstein 19
Brooklyn 18
Chicago 17
Auburn Hills 16
Hefei 16
Redwood City 16
Toronto 16
Buffalo 15
Denver 15
Nanchang 15
Haiphong 14
Manchester 14
Boston 12
Bremen 12
Phoenix 12
San Mateo 12
Tianjin 12
Ferrara di Monte Baldo 11
Medellín 11
San Francisco 11
Shenyang 11
Stockholm 11
Biên Hòa 10
Changsha 10
Da Nang 10
Dublin 10
Hebei 10
Lahore 10
Moscow 10
Mountain View 10
Turin 10
Chennai 9
Istanbul 9
Montevideo 9
Padova 9
Poplar 9
Washington 9
Florence 8
Jinan 8
New Delhi 8
Norwalk 8
Philadelphia 8
Amsterdam 7
Augusta 7
Baghdad 7
Bexley 7
Charlotte 7
Columbus 7
Jeddah 7
Jiaxing 7
Ningbo 7
Totale 6.777
Salva come PNG Salva come JPEG
Nome #
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 287
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 286
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 283
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 253
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 242
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 239
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 237
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 237
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 236
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 234
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 225
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 222
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 219
Pharmacological characterization of tachykinin tetrabranched derivatives 212
Physicochemical stability of cabazitaxel and docetaxel solutions 210
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 206
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 204
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 196
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 196
Structure-activity study at positions 3 and 4 of human neuropeptide S. 194
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 193
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 190
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 189
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 185
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 184
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 183
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 179
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 178
Structure-activity relationship study on human urotensin II 173
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 172
Synthesis of 2,6-Dimethyltyrosine-Like Amino Acids through Pinacolinamide-Enabled C-H Dimethylation of 4-Dibenzylamino Phenylalanine 171
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 168
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 167
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 166
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 165
Synthesis and antimicrobial activity of dermaseptin S1 analogues 160
Thermodynamic and spectroscopic investigation on the role of Met residues in CuII binding to the non-octarepeat site of the human prion protein 160
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 160
Novel Mixed NOP/Opioid Receptor Peptide Agonists 157
How terminal protection affects the chemical and biological properties of the antimicrobial calcitermin 154
Role of 2′,6′-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds 145
CCR4+ CD8+ T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis 133
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 133
Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin 129
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 128
The N-terminal domain of Helicobacter pylori's Hpn protein: The role of multiple histidine residues 119
Manganese complexes for multimodal PET/MRI imaging: progress of METRICS project 114
METRICS project: Synthesis of Manganese Complexes as potential PET/MRI Agents 112
Synthesis and characterization of manganese dithiocarbamate complexes: New evidence of dioxygen activation 101
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 94
null 94
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 91
Positively charged residues play a significant role in enhancing the antibacterial activity of calcitermin 86
Production and Characterization of Semi-Solid Formulations for the Delivery of the Cosmetic Peptide Palmitoyl-GHK 76
Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity 75
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 59
null 42
Totale 9.803
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 568
Totale 43.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 0 0 0 0 71 95 41
2021/2022595 28 53 47 42 33 14 35 37 37 51 55 163
2022/2023485 58 31 26 54 62 50 55 50 46 2 29 22
2023/2024396 31 41 26 10 16 90 17 46 10 11 18 80
2024/20251.453 35 29 146 62 175 142 28 71 255 129 188 193
2025/20263.928 460 158 329 481 624 322 532 229 352 441 0 0
Totale 9.803